Best VCs for Bioeconomy

Managing Partner

Forbion

Dirk Kersten invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thro

Managing Partner

Forbion

Geert-Jan Mulder invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage

Managing Partner

Forbion

Sander Slootweg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage t

Managing Partner & CFO

Forbion

Martien van Osch is listed in a Managing Partner & CFO capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and

General Partner

Forbion

Jon Edwards invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throu

General Partner

Forbion

Nanna Lüneborg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

General Partner

Forbion

Marco Boorsma invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

General Partner

Forbion

Jasper Bos invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throug

General Partner

Forbion

Joy Faucher invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throu

General Partner

Forbion

Alexander Hoffmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stag

General Partner

Forbion

Dmitrij Hristodorov invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early sta

General Partner

Forbion

Wouter Joustra invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

General Partner

Forbion

Rogier Rooswinkel invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage

General Partner IR & Impact

Forbion

Robbert van de Griendt is listed in a General Partner IR & Impact capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role disti

Chief Legal Risk & Compliance Officer

Forbion

Machteld Groeneveld is listed in a Chief Legal Risk & Compliance Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the rol

Chief Accounting Officer

Forbion

Wilfred Kevelam is listed in a Chief Accounting Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and

Partner

Forbion

Regina Salvat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Partner, Investor Relations

Forbion

Thijs Verburg is listed in a Partner, Investor Relations capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an

Partner

Forbion

Mathias Vinther invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage t

Principal

Forbion

Audrey Cacaly invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Principal

Forbion

Vanessa Carle invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Principal

Forbion

Morgan Haller invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Principal

Forbion

Meike Logtenberg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage

Principal

Forbion

Tim Lohoff invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throug

Senior Associate

Forbion

Carolin Lanfer invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

Senior Associate

Forbion

Gilles van Tienderen invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early st

Senior Associate

Forbion

Melanie de Almeida invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stag

Senior Associate

Forbion

Kanay Khakhria invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

Associate

Forbion

Maximilien Souvereyns invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early s

Senior Analyst

Forbion

Luuk de Vries invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Senior Analyst

Forbion

Roberto Hofmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage t

Senior Analyst

Forbion

Joseph Iwasyk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Senior Analyst

Forbion

Sarah Neshat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thro

Analyst

Forbion

Nat Kolber invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throug

Analyst

Forbion

Charlotte Koldeweij invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early sta

Analyst

Forbion

Vincent Loon invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thro

Analyst

Forbion

Vivien Veninga invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

Fellow

Forbion

James Bayne is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's manda

Fellow, BioEconomy

Forbion

Alice Evans is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

Fellow, BioEconomy

Forbion

Sebastien Garnier is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and use

Fellow

Forbion

Maja Wojtynska is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's ma

Operating Partner

Forbion

Per Falholt is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f

Operating Partner, Talent Acquisition

Forbion

Rory Gummerson is listed in a Operating Partner, Talent Acquisition capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role dis

Operating Partner

Forbion

Peter Høngaard Andersen is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an

Operating Partner

Forbion

Carlo Incerti is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

Operating Partner

Forbion

John J.P. Kastelein is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and us

Operating Partner

Forbion

Ton Logtenberg is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses th

Operating Partner

Forbion

John McDonald is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

Operating Partner

Forbion

John Montana is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

Operating Partner

Forbion

Gijs van den Brink is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and use

Operating Partner

Forbion

Sander van Deventer is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and us

Venture Partner

Forbion

Philip Astley-Sparke invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early st

Venture Partner

Forbion

Josh Brumm invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throug

Venture Partner

Forbion

Matt Cooper invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throu

Venture Partner

Forbion

Cees de Jong invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thro

Venture Partner

Forbion

Michael Hayden invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

Venture Partner

Forbion

Gökben Koca invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage throu

Venture Partner

Forbion

Jonathan McNeill invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage

Venture Partner

Forbion

Yigal M. Pinto invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage th

Venture Partner

Forbion

Patrick Round invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Venture Partner

Forbion

Onno van de Stolpe invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stag

Venture Partner

Forbion

Patrick Vink invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thro

Venture Partner

Forbion

Jens Wendland invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Advisor

Forbion

Michael Burgess is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's

Advisor

Forbion

Simon J Clark is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's ma

Advisor

Forbion

John Ford is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandat

Advisor

Forbion

Scott Friedman is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's m

Advisor

Forbion

Frank G. Holz is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's ma

Advisor

Forbion

An Michiels is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mand

Advisor

Forbion

Stefan Oschmann is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's

Senior Advisor

Forbion

Holger Reithinger is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses th

Advisor

Forbion

Steen Riisgaard is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's

Advisor

Forbion

Liz Rodgers is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mand

Advisor

Forbion

Floor Saris is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mand

Senior Advisor

Forbion

Feike Sijbesma is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f

Venture Advisor

Forbion

Alice Vickers is listed in a Venture Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f

Head of Marketing & Communications

Forbion

Laura Asbjornsen is listed in a Head of Marketing & Communications capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role dist

Head of Impact and ESG

Forbion

Silva Dezelan is listed in a Head of Impact and ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and use

Vice President Finance

Forbion

Jennifer Fritzsche is listed in a Vice President Finance capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an

Vice President Finance - Funds

Forbion

Cyril Lesser is listed in a Vice President Finance - Funds capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction

Head of Tax

Forbion

Arjan Oosterheert is listed in a Head of Tax capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the f

Head of Public Affairs

Forbion

Marc van Voorst tot Voorst is listed in a Head of Public Affairs capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distin

Investor Relations Director

Forbion

Joost de Rijk is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction an

Marketing & Communications Director

Forbion

Lior Alperovich is listed in a Marketing & Communications Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role dist

Senior Associate, Impact & ESG

Forbion

Vincent Conijn is listed in a Senior Associate, Impact & ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinctio

Finance Manager

Forbion

Bart de Jong is listed in a Finance Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the fi

Senior Paralegal

Forbion

Baris Duvan is listed in a Senior Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the fi

Fund Controller

Forbion

Marnix Groot is listed in a Fund Controller capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the fi

Finance Director

Forbion

Stijn Jochemsen is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses th

HR Administrator

Forbion

Francine MacLeod invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage

Finance Director

Forbion

Walter Schram is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

IT Solution Architect

Forbion

Devan Sequeira is listed in a IT Solution Architect capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and use

Legal Counsel

Forbion

Thijs van Egmond is listed in a Legal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the

Finance Director

Forbion

Pascal van Wees is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses th

Deal Counsel

Forbion

Iris Veldman is listed in a Deal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm'

AI Specialist

Forbion

Viktorija Vodilovska is listed in a AI Specialist capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses

AML/KYC Manager

Forbion

Patricia Vonk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage thr

Paralegal

Forbion

Maureen Wouters is listed in a Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm'

Investor Relations Director

Forbion

Rachelle Young is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction a

Executive Assistant

Forbion

Danielle de Magalhães invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early s